Literature DB >> 12112117

Diffuse signal abnormalities in the spinal cord in multiple sclerosis: direct postmortem in situ magnetic resonance imaging correlated with in vitro high-resolution magnetic resonance imaging and histopathology.

Elisabeth Bergers1, Joost C J Bot, Paul van der Valk, Jonas A Castelijns, Geert J Lycklama a Nijeholt, Wouter Kamphorst, Chris H Polman, Erwin L A Blezer, Klaas Nicolay, Rivka Ravid, Frederik Barkhof.   

Abstract

In this study, we compared direct postmortem in situ (whole-corpse) sagittal spinal cord magnetic resonance imaging (1.5T) of 7 multiple sclerosis cases with targeted high-resolution in vitro axial magnetic resonance imaging (4.7T) and histopathology. On sagittal in situ magnetic resonance imaging, 1 case had a normal spinal cord, 2 had only focal lesions, 3 had a combination of focal and diffuse abnormalities, and 1 had only diffuse abnormalities. All spinal cords showed abnormalities on high-resolution magnetic resonance imaging and histopathology, confirming the existence of diffuse cord changes as genuine multiple sclerosis-related abnormalities while highlighting the limited resolution of in vivo magnetic resonance imaging.

Entities:  

Mesh:

Year:  2002        PMID: 12112117     DOI: 10.1002/ana.10170

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  11 in total

1.  Improved Lesion Detection by Using Axial T2-Weighted MRI with Full Spinal Cord Coverage in Multiple Sclerosis.

Authors:  S Galler; J-P Stellmann; K L Young; D Kutzner; C Heesen; J Fiehler; S Siemonsen
Journal:  AJNR Am J Neuroradiol       Date:  2016-01-07       Impact factor: 3.825

Review 2.  Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 1-Mechanisms, Efficacy, and Safety.

Authors:  C McNamara; G Sugrue; B Murray; P J MacMahon
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

3.  Cadaveric tissue donation: a pathologist's perspective.

Authors:  P J van Diest; N W J Lopes Cardoso; J Niesing
Journal:  J Med Ethics       Date:  2003-06       Impact factor: 2.903

Review 4.  Spinal cord MRI in multiple sclerosis--diagnostic, prognostic and clinical value.

Authors:  Hugh Kearney; David H Miller; Olga Ciccarelli
Journal:  Nat Rev Neurol       Date:  2015-05-26       Impact factor: 42.937

5.  Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.

Authors:  Jiwon Oh; Kathleen Zackowski; Min Chen; Scott Newsome; Shiv Saidha; Seth A Smith; Marie Diener-West; Jerry Prince; Craig K Jones; Peter C M Van Zijl; Peter A Calabresi; Daniel S Reich
Journal:  Mult Scler       Date:  2012-08-13       Impact factor: 6.312

Review 6.  Progressive multiple sclerosis and gray matter pathology: an MRI perspective.

Authors:  Matilde Inglese; Niels Oesingmann; Patrizia Casaccia; Lazar Fleysher
Journal:  Mt Sinai J Med       Date:  2011 Mar-Apr

Review 7.  Diffusion imaging in multiple sclerosis: research and clinical implications.

Authors:  M Inglese; Maxim Bester
Journal:  NMR Biomed       Date:  2010-08       Impact factor: 4.044

8.  Chemical exchange saturation transfer of the cervical spinal cord at 7 T.

Authors:  Adrienne N Dula; Siddharama Pawate; Lindsey M Dethrage; Benjamin N Conrad; Blake E Dewey; Robert L Barry; Seth A Smith
Journal:  NMR Biomed       Date:  2016-07-26       Impact factor: 4.044

9.  Medulla oblongata volume: a biomarker of spinal cord damage and disability in multiple sclerosis.

Authors:  Z Liptak; A M Berger; M P Sampat; A Charil; O Felsovalyi; B C Healy; P Hildenbrand; S J Khoury; H L Weiner; R Bakshi; C R G Guttmann
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-12       Impact factor: 3.825

10.  Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?

Authors:  Francesco Grussu; Torben Schneider; Carmen Tur; Richard L Yates; Mohamed Tachrount; Andrada Ianuş; Marios C Yiannakas; Jia Newcombe; Hui Zhang; Daniel C Alexander; Gabriele C DeLuca; Claudia A M Gandini Wheeler-Kingshott
Journal:  Ann Clin Transl Neurol       Date:  2017-08-15       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.